Genenta Science S.p.A GNTA
NASDAQ GNTA
$0.66 +0.02 (+3.12%)
As of: Oct 22, 2026 · 9:55 AM EDT

Genenta Science S.p.A (GNTA) Convertible Debt (2025)

Updated

Genenta Science S.p.A's Convertible Debt came in at $8.55 million for the quarter ended Jun 30, 2025.

Analysis

Genenta Science S.p.A (GNTA) Convertible Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.12 Bn 1,134.70 Bn 19.71 Bn
2 Johnson & Johnson 634.67 Bn 553.20 Bn 17.26 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn
4 Merck 377.66 Bn 332.04 Bn 12.21 Bn
5 Novartis Ag 303.82 Bn 267.81 Bn 11.24 Bn
6 Astrazeneca 266.80 Bn 240.49 Bn 12.86 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn
8 Gilead Sciences 193.45 Bn 167.65 Bn 6.22 Bn
9 Pfizer 172.20 Bn 118.84 Bn 10.94 Bn
10 Genenta Science S.p.A 13.01 Mn -72.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 8.86 Mn
API Access

Genenta Science S.p.A Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=GNTA&period=max&api_key=YOUR_API_KEY